FDA authorizes Pfizer COVID antiviral pill for high-risk individuals

Posted on AllSides December 22nd, 2021
From The Center
Photo courtesy of Pfizer Inc.

The Food and Drug Administration on Wednesday authorized Pfizer's antiviral pill for the treatment of individuals at high risk of severe illness from COVID-19.

Why it matters: At-home COVID-19 treatments, especially Pfizer's Paxlovid, are seen as possible game-changers for the pandemic. The emergency use authorization comes as the U.S. sees a surge in new COVID-19 cases and hospitalizations largely driven by the Omicron variant.

Driving the news: Pfizer released new data last week confirming Paxlovid reduced the risk of hospitalization or death by 89% in high-risk adults, Axios' Tina Reed reports.

An interim analysis of a second study of...

Read full story

Axios

AllSides Media Bias Rating: Center
AllSides Media Bias Rating: Center
106692/84300
See full bias rating for Axios
Learn about media bias
https://www.axios.com/fda-pfizer-covid-antiviral-pill-paxlovid-authorization-274ee4ed-3b4e-49c1-afbf-b5861dc2ef2c.html

More News about Coronavirus from the Left, Center and Right

From the Left

From the Center

From the Right